SEC 13F Intelligence

Altium Capital Management LLC / ALDX

Altium Capital Management LLC’s Aldeyra Therapeutics Inc Position

Does Altium Capital Management LLC own Aldeyra Therapeutics Inc (ALDX)? Not currently — the last reported position was 864.0K shares worth $8M in Q3 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$8M
Q3 2021
Shares
864.0K
% of Portfolio
+1.99%
Quarters Held
3
position exited

Position History ALDX

Reported value by quarter
Q1 ’21: $7MQ1 ’21Q2 ’21: $10MQ2 ’21Q3 ’21: $8MQ3 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2021864.0K$8M+1.99%
Q2 2021864.0K$10M+2.27%
Q1 2021548.2K$7M+1.81%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of ALDX.